Supplementary Table 5 from Phase II, Randomized Study of Spartalizumab (PDR001), an Anti–PD-1 Antibody, versus Chemotherapy in Patients with Recurrent/Metastatic Nasopharyngeal Cancer
Authors:
- Caroline EvenCECaroline Even
- Hung-Ming WangHWHung-Ming Wang
- Shau-Hsuan LiSLShau-Hsuan Li
- Roger K-C NganRNRoger K-C Ngan
- Arunee DechaphunkulADArunee Dechaphunkul
- Li ZhangLZLi Zhang
- Chia-Jui YenCYChia-Jui Yen
- Po Chung ChanPCPo Chung Chan
- Somvilai ChakrabandhuSCSomvilai Chakrabandhu
- Brigette B.Y. MaBMBrigette B.Y. Ma
- Suebpong TanasanvimonSTSuebpong Tanasanvimon
- Victor H.F. LeeVLVictor H.F. Lee
Open Access
- 31 March 2023
- other
- Published by American Association for Cancer Research (AACR)